Literature DB >> 31039099

Can 7 or 30-Day Recall Questions Capture Self-Reported Lower Urinary Tract Symptoms Accurately?

Kathryn E Flynn1, Sarah A Mansfield2, Abigail R Smith2, Brenda W Gillespie3, Catherine S Bradley4, David Cella5, J Quentin Clemens3, Margaret E Helmuth2, H Henry Lai6, Ziya Kirkali7, Pooja Talaty8, Kevin P Weinfurt9.   

Abstract

PURPOSE: Self-reported measurement tools often provide a recall period, eg "In the past 7 days…" For lower urinary tract symptoms the concordance of end of day (daily) reports with 7 and 30-day recalled reports is unknown to our knowledge. We evaluated how accurately 7 or 30-day recall questions capture lower urinary tract symptoms.
MATERIALS AND METHODS: The 261 female and 254 male participants were recruited from a total of 6 United States tertiary care sites. We evaluated 18 items representing 7 symptoms covering storage, voiding and post-micturition symptoms. Item responses on the daily forms were averaged for a 7 or a 30-day period and compared to the corresponding 7 or 30-day recall version of the item. Analyses were item and gender specific. Within person concordance was assessed using the Pearson correlation. Bias (systematic overreporting or underreporting) was calculated as the difference between the recalled item and the averaged daily item score, and reported as a percent of the item scale.
RESULTS: All correlations exceeded 0.60. Correlations between averaged daily reports and recalled reports ranged from 0.72 to 0.89 for 7 days and from 0.71 to 0.91 for 30 days among women, and from 0.68 to 0.90 and 0.68 to 0.95, respectively, among men. Most items did not show systematic bias and the median percent bias did not exceed 10% for any item. However, bias exceeding ±10% for some items was observed in a subset of individuals.
CONCLUSIONS: Recalled reports during the 7 and 30 days tracked well with averaged daily reports for men and women. Systematic bias was minimal, suggesting that 7 and 30-day recall periods for self-reported lower urinary tract symptoms are reasonable.

Entities:  

Keywords:  lower urinary tract symptoms; mental recall; observer variation; time factors

Mesh:

Year:  2019        PMID: 31039099      PMCID: PMC6905458          DOI: 10.1097/JU.0000000000000310

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  The International Consultation on Incontinence Modular Questionnaire: www.iciq.net.

Authors:  Paul Abrams; Kerry Avery; Nikki Gardener; Jenny Donovan
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

2.  The urinary diary in evaluation of incontinent women: a test-retest analysis.

Authors:  J F Wyman; S C Choi; S W Harkins; M S Wilson; J A Fantl
Journal:  Obstet Gynecol       Date:  1988-06       Impact factor: 7.661

3.  Accuracy of 30-day recall for components of sexual function and the moderating effects of gender and mood.

Authors:  Kevin P Weinfurt; Li Lin; Carrie B Dombeck; Joan E Broderick; Denise C Snyder; Megan S Williams; Maria R Fawzy; Kathryn E Flynn
Journal:  J Sex Med       Date:  2013-06-26       Impact factor: 3.802

4.  Variability of momentary pain predicts recall of weekly pain: a consequence of the peak (or salience) memory heuristic.

Authors:  Arthur A Stone; Joseph E Schwartz; Joan E Broderick; Saul S Shiffman
Journal:  Pers Soc Psychol Bull       Date:  2005-10

5.  National community prevalence of overactive bladder in the United States stratified by sex and age.

Authors:  Karin S Coyne; Chris C Sexton; Vasudha Vats; Christine Thompson; Zoe S Kopp; Ian Milsom
Journal:  Urology       Date:  2011-01-22       Impact factor: 2.649

6.  Women overestimate daytime urinary frequency: the importance of the bladder diary.

Authors:  Kobi Stav; Peter L Dwyer; Anna Rosamilia
Journal:  J Urol       Date:  2009-03-17       Impact factor: 7.450

7.  The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.

Authors:  Karin S Coyne; Chris C Sexton; Debra E Irwin; Zoe S Kopp; Con J Kelleher; Ian Milsom
Journal:  BJU Int       Date:  2008-06       Impact factor: 5.588

8.  Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q.

Authors:  K Coyne; D Revicki; T Hunt; R Corey; W Stewart; J Bentkover; H Kurth; P Abrams
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

9.  Voiding frequency in a sample of asymptomatic American men.

Authors:  Jerilyn M Latini; Elizabeth Mueller; Matthew M Lux; Mary Pat Fitzgerald; Karl J Kreder
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

10.  Cluster analysis and lower urinary tract symptoms in men: findings from the Boston Area Community Health Survey.

Authors:  Amy Cinar; Susan A Hall; Carol L Link; Steven A Kaplan; Zoe S Kopp; Claus G Roehrborn; Raymond C Rosen
Journal:  BJU Int       Date:  2008-05       Impact factor: 5.588

View more
  4 in total

1.  Patient demographic and psychosocial characteristics associated with 30-day recall of self-reported lower urinary tract symptoms.

Authors:  Kathryn E Flynn; Sarah A Mansfield; Abigail R Smith; Brenda W Gillespie; Catherine S Bradley; David Cella; Margaret E Helmuth; H Henry Lai; Ziya Kirkali; Pooja Talaty; James W Griffith; Kevin P Weinfurt
Journal:  Neurourol Urodyn       Date:  2020-07-23       Impact factor: 2.696

2.  Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer.

Authors:  Elisabeth M Schaffer; Ethan M Basch; Gisela M Schwab; Antonia V Bennett
Journal:  Clin Trials       Date:  2021-04-22       Impact factor: 2.486

3.  AUGS-PERFORM: A New Patient-Reported Outcome Measure to Assess Quality of Prolapse Care.

Authors:  Michele O'Shea; Sarah Boyles; Catherine S Bradley; Kristin Jacobs; Molly McFatrich; Vivian Sung; Kevin Weinfurt; Nazema Y Siddiqui
Journal:  Female Pelvic Med Reconstr Surg       Date:  2022-06-22       Impact factor: 1.913

4.  Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19.

Authors:  Nan Hong; Wangshu Yu; Jianhua Xia; Ye Shen; Maurice Yap; Wei Han
Journal:  Acta Ophthalmol       Date:  2020-04-26       Impact factor: 3.761

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.